tiprankstipranks
Trending News
More News >
NATCO Pharma Limited (IN:NATCOPHARM)
:NATCOPHARM
India Market

NATCO Pharma Limited (NATCOPHARM) Income Statement

Compare
6 Followers

NATCO Pharma Limited Income Statement

Last quarter (Q3 2025), NATCO Pharma Limited's total revenue was ₹4.75B, a decrease of -37.41% from the same quarter last year. In Q3, NATCO Pharma Limited's net income was ₹1.33B. See NATCO Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 44.30B₹ 40.02B₹ 27.07B₹ 19.05B₹ 20.56B
Gross Profit
₹ 29.10B₹ 31.39B₹ 20.80B₹ 12.23B₹ 15.24B
Operating Expenses
₹ 9.49B₹ 15.39B₹ 13.08B₹ 10.81B₹ 5.93B
Depreciation and Amortization
₹ 2.35B₹ 1.87B₹ 1.64B₹ 1.43B₹ 1.13B
EBITDA
₹ 25.50B₹ 18.80B₹ 10.40B₹ 3.63B₹ 6.07B
Operating Income
₹ 19.61B₹ 25.96B₹ 8.76B₹ 2.20B₹ 9.31B
Other Income/Expenses
₹ 3.31B₹ -9.23B₹ -6.30B₹ -4.91B₹ -3.52B
Pretax Income
₹ 22.91B₹ 16.73B₹ 8.62B₹ 2.02B₹ 5.80B
Net Income
₹ 18.85B₹ 13.88B₹ 7.15B₹ 1.70B₹ 4.41B
Per Share Metrics
Basic EPS
₹ 105.26₹ 77.34₹ 39.18₹ 9.32₹ 24.20
Diluted EPS
₹ 105.26₹ 77.34₹ 39.18₹ 9.32₹ 24.16
Weighted Average Shares Outstanding
179.12M 179.51M 182.55M 182.37M 182.16M
Weighted Average Shares Outstanding (Diluted)
179.12M 179.50M 182.55M 182.41M 182.49M
Currency in INR

NATCO Pharma Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis